-
公开(公告)号：US20220257607A1
公开(公告)日：2022-08-18
申请号：US17629824
申请日：2020-04-23
Applicant: Amgen Inc.
Inventor： Ron C. KELLY , Michael T. KENNEDY , Stevedat K. LA
Abstract: Formulations of compounds of Formula I are provided as are doses and dosing regimens useful in methods of treating cancer including hematological malignances such as acute myelogenous leukemia, multiple myeloma, and non-Hodgkin's lymphoma.
Search Results
1
records
(took 0.011 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
